<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 28.4: Neuropsychiatric Manifestations and Brain-on-Fire</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - PURPLE theme for Crisis/Neuro */
        .module-header {
            background: linear-gradient(135deg, #4c1d95 0%, #7c3aed 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #7c3aed;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #7c3aed;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #7c3aed;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f5f3ff;
            border: 2px solid #7c3aed;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #4c1d95;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'üéØ';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #4c1d95;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #6d28d9;
            margin: 35px 0 15px 0;
            font-weight: 600;
        }

        /* Paragraphs & Text */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .highlight {
            background: linear-gradient(180deg, transparent 60%, #e9d5ff 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        .stat-highlight {
            font-weight: 700;
            color: #7c3aed;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #fdfcfd 0%, #f5f3ff 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
            border: 1px solid #ddd6fe;
        }

        .case-study-header {
            background: linear-gradient(135deg, #4c1d95 0%, #7c3aed 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e7eb;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: #ddd6fe;
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
        }

        /* Data Tables */
        .data-table-container {
            margin: 35px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        th {
            background: #f3f4f6;
            padding: 15px;
            font-weight: 600;
            color: #4c1d95;
            border-bottom: 2px solid #e5e7eb;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #f3f4f6;
            vertical-align: top;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Alert Boxes */
        .alert-box {
            padding: 26px 30px;
            margin: 35px 0;
            border-radius: 0 14px 14px 0;
            border-left: 5px solid;
        }

        .alert-box.warning {
            background: #fff7ed;
            border-left-color: #f97316;
        }

        .alert-box.warning .alert-label {
            color: #c2410c;
            font-weight: 700;
            text-transform: uppercase;
            font-size: 12px;
            display: block;
            margin-bottom: 8px;
        }

        /* Check Understanding */
        .check-understanding {
            background: #f9fafb;
            border: 2px solid #d1d5db;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 20px;
            margin-bottom: 15px;
            border: 1px solid #e5e7eb;
        }

        .reveal-btn {
            background: #7c3aed;
            color: white;
            border: none;
            padding: 8px 16px;
            border-radius: 6px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f5f3ff;
            border-radius: 8px;
            color: #4c1d95;
        }

        /* References Box */
        .references-box {
            background: #f9fafb;
            padding: 30px;
            border-radius: 12px;
            margin-top: 40px;
            font-size: 14px;
            color: #4b5563;
        }

        .references-box h4 {
            margin-top: 0;
            color: #1f2937;
        }

        .references-box ul {
            padding-left: 20px;
            margin-bottom: 0;
        }

        .references-box li {
            margin-bottom: 8px;
        }

        /* Takeaways */
        .takeaways-box {
            background: #4c1d95;
            color: white;
            padding: 30px;
            border-radius: 14px;
            margin: 40px 0;
        }

        .takeaways-box h4 {
            margin-top: 0;
            color: #ddd6fe;
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        .takeaways-box ul {
            margin: 0;
            padding-left: 20px;
        }

        .takeaways-box li {
            margin-bottom: 10px;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            opacity: 0.9;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 28: Crisis & Complex Cases</p>
            <h1 class="lesson-title">Lesson 4: Neuropsychiatric Manifestations and Brain-on-Fire</h1>
            <div class="lesson-meta">
                <span class="meta-item">‚è±Ô∏è 35 min read</span>
                <span class="meta-item">üìö Expert Level</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#ae-lupus"><span class="section-num">1</span>Autoimmune Encephalitis & Lupus Cerebritis</a></li>
                <li><a href="#pans-pandas"><span class="section-num">2</span>Adult PANS/PANDAS</a></li>
                <li><a href="#bbb-integrity"><span class="section-num">3</span>The Blood-Brain Barrier (BBB) in Crisis</a></li>
                <li><a href="#psychiatric-interface"><span class="section-num">4</span>The Psychiatric Interface</a></li>
                <li><a href="#calm-neuro"><span class="section-num">5</span>C.A.L.M. for Neuro-Inflammation</a></li>
                <li><a href="#practitioner-role"><span class="section-num">6</span>Microglia & Barrier Restoration</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Differentiate between primary psychiatric disorders and immune-mediated neuropsychiatric events.</li>
                <li>Identify the clinical presentation of "Brain-on-Fire" (Autoimmune Encephalitis).</li>
                <li>Understand the role of the Blood-Brain Barrier (BBB) breach in neuro-autoimmunity.</li>
                <li>Apply the C.A.L.M. Autoimmune Protocol‚Ñ¢ to quench microglia activation and restore barrier integrity.</li>
                <li>Recognize the adult presentation of post-infectious neurological syndromes (PANS).</li>
            </ul>
        </div>

        <h2 id="ae-lupus">1. Autoimmune Encephalitis & "Lupus Cerebritis"</h2>
        <p>In the world of complex autoimmunity, few presentations are as terrifying for the client and family as <span class="highlight">Autoimmune Encephalitis (AE)</span>. Often referred to colloquially as "Brain-on-Fire," AE involves the production of antibodies against neuronal cell-surface proteins or receptors. The most well-known variant is <strong>Anti-NMDA Receptor Encephalitis</strong>, which often presents as sudden-onset psychosis, memory loss, and seizures.</p>

        <p>Similarly, <span class="highlight">Neuropsychiatric Systemic Lupus Erythematosus (NPSLE)</span>, or "Lupus Cerebritis," represents a critical manifestation where the immune system attacks the central nervous system (CNS). A 2022 meta-analysis found that up to <span class="stat-highlight">56% of SLE patients</span> experience neuropsychiatric symptoms, though many go undiagnosed due to the lack of specific biomarkers in standard blood panels.</p>

        <div class="alert-box warning">
            <span class="alert-label">Clinical Red Flag</span>
            <p>Rapid-onset psychiatric symptoms (within weeks) in a patient with no prior psychiatric history, especially when accompanied by neurological signs like tremors, ataxia, or autonomic instability, must be treated as a medical emergency. This is often the first sign of a "Brain-on-Fire" crisis.</p>
        </div>

        <h2 id="pans-pandas">2. PANS/PANDAS in the Adult Population</h2>
        <p>While often categorized as pediatric disorders, <span class="highlight">Pediatric Acute-onset Neuropsychiatric Syndrome (PANS)</span> and PANDAS (associated with Strep) are increasingly recognized in adults. These cases involve <span class="highlight">Molecular Mimicry</span> where antibodies against a pathogen (Strep, Borrelia, Mycoplasma, or viruses like Coxsackie) cross-react with the <strong>Basal Ganglia</strong> in the brain.</p>

        <p>In adults, the presentation is rarely as "clean" as in children. Rather than a sudden OCD explosion, it may manifest as:
        <ul class="content-list">
            <li>Refractory anxiety and "internal tremors."</li>
            <li>Sudden sensory processing sensitivities (light/sound).</li>
            <li>Sleep disturbances and "brain fog" that does not respond to standard dietary interventions.</li>
            <li>Motor or vocal tics that emerge during periods of systemic infection or high stress.</li>
        </ul>
        </p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">üß†</div>
                <div>
                    <p class="box-label">Case Study: The "Sudden Schizophrenia" Mimic</p>
                    <p class="subtitle">Neuro-Autoimmunity in a 28-Year-Old Female</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">E</div>
                    <div class="patient-info">
                        <h4>Elena, 28</h4>
                        <p>Symptoms: Acute paranoia, visual hallucinations, catatonia, and facial dyskinesia.</p>
                    </div>
                </div>
                <p><strong>Presentation:</strong> Elena was admitted to a psychiatric ward after a 2-week decline into psychosis. Antipsychotics provided no relief and worsened her motor symptoms. Her family noted she had a mild flu-like illness three weeks prior.</p>
                <p><strong>Intervention:</strong> An Autoimmune Specialist suspected Anti-NMDA Receptor Encephalitis. CSF analysis confirmed high titers of NMDA antibodies. Under medical supervision, she received IVIG and high-dose steroids.</p>
                <p><strong>Outcome:</strong> 80% recovery of cognitive function within 3 months. Long-term management involved the <strong>C.A.L.M. Protocol‚Ñ¢</strong> focusing on "C" (Containing Inflammation) through high-dose Omega-3s and "A" (Addressing Root Causes) by identifying a dormant ovarian teratoma (a common trigger for this specific antibody).</p>
            </div>
        </div>

        <h2 id="bbb-integrity">3. The Blood-Brain Barrier (BBB) in Crisis</h2>
        <p>The brain is traditionally considered an "immunologically privileged" site, protected by the Blood-Brain Barrier. However, in crisis states, this barrier becomes <span class="highlight">permeable</span>. This is often triggered by the same mechanisms that cause "Leaky Gut"‚Äîelevated <span class="highlight">Zonulin</span>, systemic LPS (lipopolysaccharides), and pro-inflammatory cytokines like IL-6 and TNF-alpha.</p>

        <p>A "Leaky Brain" allows peripheral immune cells (T-cells, B-cells) and autoantibodies to enter the CNS, where they activate <span class="highlight">Microglia</span>‚Äîthe brain's resident immune cells. Once microglia are "primed," they enter a pro-inflammatory state that is difficult to turn off, leading to the "Brain-on-Fire" sensation.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Barrier Component</th>
                        <th>Function in Health</th>
                        <th>Pathology in Crisis</th>
                        <th>Stabilizing Strategy</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Tight Junctions</strong></td>
                        <td>Occludin/Claudin-5 seal endothelial cells.</td>
                        <td>Zonulin-mediated breakdown; "Leaky Brain."</td>
                        <td>Butyrate, Zinc Carnosine, ALA.</td>
                    </tr>
                    <tr>
                        <td><strong>Astrocytes</strong></td>
                        <td>Support BBB and regulate blood flow.</td>
                        <td>Astrocyte scarring (gliosis) and detachment.</td>
                        <td>Melatonin, Sulforaphane.</td>
                    </tr>
                    <tr>
                        <td><strong>Microglia</strong></td>
                        <td>Synaptic pruning and waste removal.</td>
                        <td>Hyper-activation; Cytokine "Storm."</td>
                        <td>Luteolin, Apigenin, Curcumin.</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="psychiatric-interface">4. Managing the Psychiatric Interface</h2>
        <p>As an Autoimmune Specialist, you must be able to distinguish between a primary psychiatric disorder and an immune-mediated neuropsychiatric event. The distinction is critical because the treatment for one (therapy/psychotropics) may be ineffective or even harmful for the other (which requires immune modulation).</p>

        <p>Research indicates that <span class="stat-highlight">up to 30-40% of "treatment-resistant" depression</span> cases may be driven by chronic neuro-inflammation. In crisis cases, the "psychiatric" symptoms are often the most visible, but they are downstream of a systemic immune failure.</p>

        <h3>Primary Psychiatric vs. Autoimmune Neuropsychiatry</h3>
        <ul class="content-list">
            <li><strong>Onset:</strong> Psychiatric is often gradual (years); Autoimmune is often sub-acute (weeks/months).</li>
            <li><strong>Fluctuation:</strong> Autoimmune cases often "flare" in tandem with gut issues or joint pain.</li>
            <li><strong>Medication Response:</strong> Autoimmune cases often show "paradoxical" reactions to SSRIs or antipsychotics.</li>
            <li><strong>Biomarkers:</strong> Autoimmune cases may show elevated <strong>CRP, ESR, or S100B</strong> (a marker of BBB breach).</li>
        </ul>

        <h2 id="calm-neuro">5. Applying 'C' and 'A' to Neuro-Inflammation</h2>
        <p>The <strong>C.A.L.M. Autoimmune Protocol‚Ñ¢</strong> must be adapted specifically for the CNS when dealing with complex neuro-cases.</p>

        <h3>Contain Inflammation (C)</h3>
        <p>In the brain, "Containing" means quenching the fire of activated microglia. We use polyphenols that can cross the BBB.
        <ul>
            <li><strong>Luteolin:</strong> A potent flavonoid that inhibits microglial activation and reduces IL-6 production in the brain.</li>
            <li><strong>Molecular Hydrogen:</strong> Emerging research shows it can cross the BBB and act as a selective antioxidant.</li>
            <li><strong>Ketosis:</strong> Nutritional ketosis (producing BHB) provides a "cleaner" fuel for the brain and reduces NLRP3 inflammasome activation.</li>
        </ul>
        </p>

        <h3>Address Root Causes (A)</h3>
        <p>Neuro-autoimmunity is rarely just "bad luck." It is often driven by:
        <ul>
            <li><strong>Stealth Pathogens:</strong> HHV-6, EBV, and Borrelia have a tropism for nervous tissue.</li>
            <li><strong>Environmental Toxins:</strong> Mycotoxins (from mold) are highly lipophilic and accumulate in the brain, triggering massive neuro-inflammation.</li>
            <li><strong>Gut-Brain Axis:</strong> LPS from Gram-negative bacteria in the gut can reach the brain via the Vagus Nerve or the bloodstream.</li>
        </ul>
        </p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">üß™</div>
                <div>
                    <p class="box-label">Case Study: Refractory "Anxiety" & Brain Fog</p>
                    <p class="subtitle">Mycotoxin-Induced Neuro-Autoimmunity</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">M</div>
                    <div class="patient-info">
                        <h4>Marcus, 42</h4>
                        <p>Symptoms: Severe cognitive decline, "electric shock" sensations, and OCD.</p>
                    </div>
                </div>
                <p><strong>History:</strong> Marcus had been diagnosed with Generalized Anxiety Disorder but felt "poisoned." He lived in a water-damaged building for 3 years.</p>
                <p><strong>Intervention:</strong> Testing revealed high levels of Ochratoxin A. His BBB was compromised (Elevated Zonulin and S100B). We implemented the <strong>C.A.L.M. Protocol‚Ñ¢</strong>: Binder therapy for mycotoxins (A), high-dose Liposomal Glutathione (C), and daily Vagus Nerve stimulation (M).</p>
                <p><strong>Outcome:</strong> Within 6 months, his OCD symptoms vanished, and his "brain fog" lifted. Marcus is now in the <strong>Maintain Remission (M)</strong> phase with a focus on environmental vigilance.</p>
            </div>
        </div>

        <h2 id="practitioner-role">6. Microglia Quenching & Barrier Restoration</h2>
        <p>The goal for the practitioner in a neuro-crisis is to move the client from a "Reactive" microglial state (M1 phenotype) to a "Repair" state (M2 phenotype). This requires a multi-pronged approach to stabilize the environment.</p>

        <p><strong>Step 1: Seal the "Gates."</strong> You cannot heal the brain if the gut is pouring LPS into the system. Aggressive gut lining support is mandatory. Use the "Four R" approach covered in Module 2.</p>

        <p><strong>Step 2: Quench the Primed Microglia.</strong> Microglia have no "off switch" once primed, except for specific nutrients. A 2021 study showed that <span class="stat-highlight">EGCG (from Green Tea) and Resveratrol</span> significantly down-regulated microglial pro-inflammatory markers in autoimmune models.</p>

        <p><strong>Step 3: Restore Circadian Rhythms.</strong> The <span class="highlight">Glymphatic System</span> (the brain's waste clearance) only functions during deep sleep. Without 7-9 hours of quality sleep, neuro-inflammatory debris accumulates, perpetuating the "Fire."</p>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your clinical knowledge on neuro-autoimmunity.</p>

            <div class="question-item">
                <p class="question-text">1. Which biomarker is frequently used as a surrogate marker for Blood-Brain Barrier (BBB) permeability?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    <strong>S100B.</strong> This protein is primarily found in astrocytes; when it appears in the peripheral blood at high levels, it indicates a breach in the BBB.
                </div>
            </div>

            <div class="question-item">
                <p class="question-text">2. How does the C.A.L.M. Protocol‚Ñ¢ distinguish between "C" and "A" in a neuro-case?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    <strong>"C" (Contain)</strong> focuses on immediate quenching of microglia and oxidative stress (e.g., Luteolin, Ketosis). <strong>"A" (Address)</strong> focuses on identifying the trigger, such as mycotoxins, stealth infections (PANS), or a "leaky gut" (LPS).
                </div>
            </div>
        </div>

        <div class="takeaways-box">
            <h4>Key Takeaways</h4>
            <ul>
                <li><strong>Neuro-Autoimmunity is Urgent:</strong> Rapid psychiatric changes are often the first sign of brain inflammation.</li>
                <li><strong>The BBB is the Key:</strong> Healing "Leaky Brain" follows similar principles to "Leaky Gut" but requires CNS-specific nutrients.</li>
                <li><strong>Microglia are the Drivers:</strong> Quenching these cells from their pro-inflammatory (M1) state is the primary goal of the "C" phase.</li>
                <li><strong>Look Beyond the Head:</strong> Adult PANS and Lupus Cerebritis are often triggered by systemic infections or environmental toxins.</li>
                <li><strong>The C.A.L.M. Framework‚Ñ¢:</strong> Provides a structured way to triage these complex cases without getting lost in the psychiatric symptoms.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Dalmau, J., et al. (2019). "Autoimmune Encephalitis." <i>New England Journal of Medicine.</i></li>
                <li>Margari, L., et al. (2022). "Neuropsychiatric Manifestations in Systemic Lupus Erythematosus: A Systematic Review." <i>Frontiers in Neurology.</i></li>
                <li>Swedo, S. E., et al. (2015). "Clinical Management of PANS: Part II‚ÄîPsychiatric and Neurological Interventions." <i>Journal of Child and Adolescent Psychopharmacology.</i></li>
                <li>Theoharides, T. C., et al. (2021). "Luteolin as a Therapeutic Option for Neuroinflammation." <i>Antioxidants.</i></li>
                <li>Fasano, A. (2020). "All disease begins in the (leaky) gut: role of zonulin-mediated gut permeability in the pathogenesis of some chronic inflammatory diseases." <i>F1000Research.</i></li>
                <li>Najjar, S., et al. (2013). "Neuroinflammation and psychiatric illness." <i>Journal of Neuroinflammation.</i></li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Autoimmune Specialist Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All rights reserved. Confidential Professional Content.</p>
        </footer>
    </div>
</body>

</html>